Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Amanda, King"'
Autor:
Eddy Xiong, Carissa Bonner, Amanda King, Zoltan Maxwell Bourne, Mark Morgan, Ximena Tolosa, Tony Stanton, Kim Greaves
Publikováno v:
JMIR Formative Research, Vol 8, p e57165 (2024)
BackgroundDynamic consent has the potential to address many of the issues facing traditional paper-based or electronic consent, including enrolling informed and engaged participants in the decision-making process. The Australians Together Health Init
Externí odkaz:
https://doaj.org/article/d528dee8abaf4960b4b1d1a56b6ab6b2
Autor:
Jihwan Hwang, Ida Dzifa Dey, Olusola Ayanlowo, Cindy Flower, Amanda King, Nicole Johnson, Uyiekpen Ima-Edomwonyi, Hakeem Olasebikan, Titilola Falasinnu, Vishnuprabu Durairaj Pandian, Ashira Blazer
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Systemic lupus erythematosus (SLE) is a complex autoimmune condition that disproportionately impacts non-White ethnic and racial groups, particularly individuals in the African diaspora who experience heightened incidence, prevalence, and adverse out
Externí odkaz:
https://doaj.org/article/4ae8ff9707014ed1bfce138e9dc77923
Autor:
Kim Greaves, Amanda King, Zoltan Bourne, Jennifer Welsh, Mark Morgan, M. Ximena Tolosa, Carissa Bonner, Tony Stanton, Michael Fryer, Rosemary Korda
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The linkage of primary care, hospital and other health registry data is a global goal, and a consent-based approach is often used. Understanding the attitudes of why participants take part is important, yet little is known about r
Externí odkaz:
https://doaj.org/article/83028c09edbd4abcbea54d3d702c8282
Publikováno v:
BMJ Paediatrics Open, Vol 5, Iss Suppl 1 (2021)
Externí odkaz:
https://doaj.org/article/2a0151831a6a4a9d931d0fa958be02f6
Autor:
Jennifer E. Johnson, Shannon Wiltsey-Stirman, Alla Sikorskii, Ted Miller, Amanda King, Jennifer L. Blume, Xuan Pham, Tiffany A. Moore Simas, Ellen Poleshuck, Rebecca Weinberg, Caron Zlotnick
Publikováno v:
Implementation Science, Vol 13, Iss 1, Pp 1-12 (2018)
Abstract Background More research on sustainment of interventions is needed, especially return on investment (ROI) studies to determine cost-benefit trade-offs for effort required to sustain and how much is gained when effective programs are sustaine
Externí odkaz:
https://doaj.org/article/9da4cbbf82ef423892d372594ff9327d
Autor:
Jonathan N. Bauman, Angela C. Doran, Amanda King-Ahmad, Raman Sharma, Gregory S. Walker, Jian Lin, Tsung H. Lin, Jean-Baptiste Telliez, Sakambari Tripathy, Theunis C. Goosen, Christopher Banfield, Bimal K. Malhotra, Martin E. Dowty
Publikováno v:
Drug Metabolism and Disposition. 50:1106-1118
Abrocitinib is an oral once-daily Janus kinase 1 selective inhibitor being developed for the treatment of moderate-to-severe atopic dermatitis. This study examined the disposition of abrocitinib in male participants following oral and intravenous adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926208d526384181f37cc80f92c02aa6
https://doi.org/10.1124/dmd.122.000829
https://doi.org/10.1124/dmd.122.000829
Autor:
Christine C. Orozco, Mikko Neuvonen, Yi-An Bi, Matthew A. Cerny, Sumathy Mathialagan, Laurie Tylaska, Brian Rago, Chester Costales, Amanda King-Ahmad, Mikko Niemi, A. David Rodrigues
Publikováno v:
Molecular Pharmaceutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fe363351e5280805205ea7705113770
https://doi.org/10.1021/acs.molpharmaceut.3c00040
https://doi.org/10.1021/acs.molpharmaceut.3c00040
Autor:
David A, Tess, Emi, Kimoto, Amanda, King-Ahmad, Manoli, Vourvahis, A David, Rodrigues, Arthur, Bergman, Ruolun, Qui, Veena, Somayaji, Yan, Weng, Kari R, Fonseca, John, Litchfield, Manthena V S, Varma
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:605-614
PF-06835919 is a first-in-class ketohexokinase inhibitor (KHKi), recently under development for the treatment of metabolic and fatty liver diseases, which inhibited organic anion transporting polypeptide (OATP)1B1 in vitro and presented drug-drug int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e35798cb3081f488864d3fc6e5ea68ef
https://doi.org/10.1002/cpt.2593
https://doi.org/10.1002/cpt.2593
Autor:
Tim F. Ryder, Arthur Bergman, Amanda King-Ahmad, Neeta B. Amin, Manjinder S. Lall, T. Eric Ballard, Amit S. Kalgutkar
Publikováno v:
Xenobiotica. 52:240-253
The disposition of the hepatoselective ACC inhibitor PF-05221304 (Clesacostat) was studied after a single 50-mg oral dose of [14C]-PF-05221304 to healthy human subjects.Mass balance was achieved with 89.9% of the administered dose recovered in urine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d416ed83ff7bb741b39073b63d5e586f
https://doi.org/10.1080/00498254.2022.2062487
https://doi.org/10.1080/00498254.2022.2062487
Autor:
Kim Greaves, Amanda King, Zoltan Bourne, Jennifer Welsh, Mark Morgan, M.Ximena Tolosa, Carissa Bonner, Tony Stanton, Michael Fryer, Rosemary Korda
Background The linkage of primary care, hospital and other health registry data is a global goal, and a consent-based approach is often used. Understanding the attitudes of why participants take part is important, yet little is known about reasons fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b24d0025ac7a321165d3f4b01da5065
https://doi.org/10.21203/rs.3.rs-2208101/v1
https://doi.org/10.21203/rs.3.rs-2208101/v1
